Patients with paraproteinemia have abnormalities in their T-cell subsets including inversion of the CD4:CD8 ratio and increased expression of activation markers. Recently, distortions in T-cell receptor (TCR) TCRAV and TCRBV gene segment expression have been reported, although the significance of these observations is unclear given the finding of clonal populations of CD8' T cells in healthy elderly individuals. We have used an extensive range of TCR V-region-specific monoclonal antibodies to assess TCRAV and TCRBV expression in patients with myeloma and paraproteinemia. TCR sequence analysis was used to assess the clonality of expansions and 3-color fluorescence-activated cell sorting analysis determined the phenotype of the expanded popula-T IS NOW REALIZED THAT paraproteinemia is common in elderly people' but that only a minority of such patients go on to develop multiple myeloma (MM).' This, together with the typical pattern of a plateau phase during chemotherapy for myeloma, has led to suggestions that immunoregulation may play a role in controlling the neoplastic B-cell clone and that escape from such control may herald development of disease relapse. Abnormalities in T-cell populations have been documented consistently in paraproteinemia and include an inversion of the normal CD4:CD8 ratio,3 coincident expansions of large granular lymphocytes,4' and increased expression of lymphocyte activation markers! Whether these changes reflect an active response to the Bcell proliferation or are secondary to disordered immunoregulation is unclear at present.
T IS NOW REALIZED THAT paraproteinemia is common in elderly people' but that only a minority of such patients go on to develop multiple myeloma (MM). ' This, together with the typical pattern of a plateau phase during chemotherapy for myeloma, has led to suggestions that immunoregulation may play a role in controlling the neoplastic B-cell clone and that escape from such control may herald development of disease relapse. Abnormalities in T-cell populations have been documented consistently in paraproteinemia and include an inversion of the normal CD4:CD8 ratio,3 coincident expansions of large granular lymphocytes,4' and increased expression of lymphocyte activation markers! Whether these changes reflect an active response to the Bcell proliferation or are secondary to disordered immunoregulation is unclear at present.
Expansions of T cells bearing specific T-cell receptor (TCR) V segments has been reported in patients with both paraproteinemia and myeloma' and was found to be particularly prominent before chemotherapy. The clonality of such expansions was not determined, and the result has to be viewed in the context of the finding of clonal populations of CD8 T cells in apparently healthy elderly individuals.8"0 To investigate the significance of these T-cell expansions, we have compared the T-cell repertoire in patients with paraproteinemia with that in healthy elderly individuals by assessing the frequency and clonality of T-cell expansions as documented by TCR V segment expression. Three-color fluorescence-activated cell sorting (FACS) analysis was used to identify the membrane phenotype of the expanded populations. UK) coated with antibodies to CD4 or CD8 followed by magnetic selection.
FACS analysis. Aliquots of 2 X IO5 cells were stained with first layer antibodies followed by rabbit antimouse fluorescein-conjugated F(ab'), fragments. Cells were washed again twice and resuspended with anti-CD4 or anti-CD8 monoclonal antibodies (MoAbs; Dako, High Wycombe, UK) directly conjugated to phycoerythrin. For 3-color FACS analysis, Tricolor-labeled CD4 and CD8 MoAbs and fluorescein isothiocyanate-conjugated MoAbs towards CD45RA. CD45R0, HLA-DR, CD28, CDllb, and CD57 were used with TCRBV-specific MoAbs stained with a phycoerythrin second layer antibody. Analysis was performed on a FACScan (Becton Dickinson, Mountain View, CA).
MoAbs. The MoAbs used were anti-TCRBVU23 (HUT-7; gift from 0. Kanagawa), anti-TCRBV2 (MPB2/D5; gift from Prof A. Boylston), anti-TCRBV3 (JOVI-3; gift from Dr M. Owen), anti-TCRBV5.1 (LC4; gift from Prof A. Boylston), anti-TCRBV5.2/3 (4-2ACI; gift from Prof A. Boylston), anti-TCRBV6.7a (OT14J; gift from Prof D. Posnett), anti-TCRBV7 (3C5), anti-TCRBV8 (MX6; gift from Prof A. Boylston), anti-TCRBV9 (MKBP2/10; gift from 0. Kanagawa), anti-TCRBV11 (C21; gift from Dr A. Lanzavecchia), anti-TCRBV12 (MCA997; Serok, Kidlington, UK), anti-TCRBV13.1 (H131; gift from P. Marrack), anti-TCRBV13.2 (H132; gift from P. Marrack), anti-TCRBV13 (gift fromDr A. Krensky), anti-TCRBV17 (gift from S. Freidman), anti-TCRBV18 (BA-62; from Immunotech, Marseille, France), anti-TCRAV2.3 (TM-19; gift from J. Grunewald), anti-TCRAV12.1 (6D6; gift from Prof M. Brenner), and anti-TCRAV24 (C15; gift from Dr A. Lanzavecchia).
TCR sequencing. TCR sequences were determined by TCR Vregion-specific polymerase chain reaction (PCR) followed by cloning into M13mp18 and sequencing. V-region-specific primers 3298 MOSS ET AL Abbreviation: ND. not done . The results are shown as in Table 1 .
Protein electrophoresis. Serum or plasma samples were run on cellulose-acetate gels followed by staining with Coomassie Blue, using standard techniques.
RESULTS

TCR repertoire in elderly controls. 'KR expression on CD4
and CD8 T cells was determined by 17 different MoAbs specific for TCR V segments (Table 1) . Within the CD4 subset, theE was little variation in expression of individual V segments between subjects. However, analysis of the CD8 subset showed a bimodal distribution of TCRBV8, TCRBV13, and TCRBV17 expression in subjects A.P., C.C., and A.B., respectively. It is now cleat that the population distribution of TCRBV expression on CD8 T cells observes a bimodal pattern: and thus, these five values represent CD8 expansions.
V-region expression within the CD4 subset of PB lymphocytes from patients showed a diffmnt picture than that which had been observed for the control group (Tables 2 and 3 was also significant. A total of 4 patients decreased below the 50% lower limit derived from controls, whereas, in 5 patients, the MoAbs collectively stained over 60% of CD4 cells, including a total of 83.1% of cells in donor M.J. It is noteworthy that four TCRBV expansions were observed in this patient.
There were frequent examples of T-cell expansions within the CD8 population. Overall, 14 expansions were defined in 9 patients, with 8 of these caused by increased expression of TCRBV3 or TCRBV6.7. The largest expansion was the 79% of T cells that stained with anti-TCRBV23 in a patient with an IgM paraproteinemia, which is by far the largest distortion in TCR repertoire that we, or others, have described.
The total percentage of CD8 T cells stained varied between 21.4% and 90%. Those patients with particularly low values are likely to possess a TCRBV expansion not detected by the MoAb. This has been proven in another patient with myeloma who was found by anchored PCR to have a monoclonal expansion of CD8 cells not detectable by the available MoAbs (P. Moss and A. Osterborg, unpublished data).
TCR sequences from V-regwn-&$ned T-cell expanswm. Once T-cell expansions had been detected on the basis of increased expression of individual TCRAV or TCRBV segments, Prw.
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( it was important to determine the clonality of these populations. TCRBVl1 expansion of patient M.B. that made up 95% of V-region expansions can be either polyclonal, oligoclonal, or all TCRBVI 1 cells at the initial time point studied. Sequenmonoclonal, and such information can be valuable in determintial analyses showed that the expansions are stable over time, ing their etiology. V-region-specific PCR was used to clone with the longest study, which persisted for 15 months, being and sequence individual TCR transcripts. on the predominant TCRBV3 clone in patient I.S. NevertheWithin the patient population, CD8 expansions were oliless, the relative contribution of clones within the expansion goclonal in all instances (Fig 1) . In every case, a single Tdid show some fluctuation, because, in this patient, a second cell clone made up at least 50% of the expansion, with expanded TCRBV3 clone was detected at the third time the largest proportion being contributed by a monoclonal point. Although representing 30% of sequences at this time, TCRBV23 expansion (patient H.R.) and a clone in the this clone had only been found on 1 occasion from 32 sequences at the initial time point. When these two sequences are aligned, they show no sequence homology at the amino P T G G T E A F acid level. In the control subjects, we found examples of both A.B. had a large oligoclonal expansion within the TCRBV17 cccackggggggactgaagctttc oligoclonal and polyclonal expansions. Specifically, subject
population, whereas subject A.P. had a TCRBV8 ex] that was polyclonal. TCR sequences were amplified from cDNA, and it is pos- quency by this method. Therefore, genomic DNA was pre- pared from subject I.S. and was amplified with the TCRBV3-specific primer followed by cloning and sequencing. A total of 54% of sequences were the same as the predominant transcript isolated from cDNA, thus showing that mRNA levels are not increased in clonally expanded T cells. Of the two CD4 expansions that were sequenced, two were oligoclonal and one was polyclonal. Indeed, in the TCRBV 13.2 expansion from patient I.D., a single transcript made up over 90% of sequences.
Comparison of CDR3 region of TCRBV6.7a T cells from a CD8 expansion. T cells that recognize the same major histocompatibility complex class-I-restricted peptide often show patterns of homology in their TCR sequences. Specifically, there tends to be conservation of TCRBV usage and conserved amino acids at critical positions within the hypervariable junctional region. Comparison of the two transcripts that were expanded in the TCRBV6.7 subset of patient M.B. is highly suggestive of selection by antigen (Fig 2) . These two transcripts together made up all 23 sequences that were cloned from the TCRBV6.7 subset and clearly originate from different T cells, because they have three nucleotide differences in the hypervariable junctional region. However, the predicted amino acid sequence is exactly the same in both cases, clearly implicating antigenic selection of clones. Currently, we do not have information on the nature of likely antigen.
Three-color FACS analPhenotype of expanded T cells.
ysis was used to assess the expression of a number of markers on the T-cell expansions. The markers chosen were CD45RA and RO (markers of naive or memory phenotype, respectively), CDl1 b, CD28, CD57, and HLA-DR. Oligoclonal CD8' T cells have been previously reported to be mainly CD45R0, CDI lb and CD57 positive.' As a direct control, the same markers were studied on T-cell populations from the same patient that had not shown a T-cell expansion.
Patient H.R. had oligoclonal expansions within both the CD4 (TCRBV17) and CD8 (TCRBV23) subsets, and these populations were examined by 3-color FACS analysis to determine the expression of several other markers. The majority of the CD4' TCRBV17 population was clearly CD28- (Fig 3A) , whereas five control subsets from both this patient and others were consistently CD28' (Fig 3B) , a marker normally found on over 99% of all CD4' T cells. Two further CD4 expansions have recently been shown to have an identical phenotype to this TCRBV17 expansion. In contrast to the CD4' TCRBV17 cells of which the majority were CD45RO', the CD8' TCRBV23 expansion was clearly CD45RA' and CD45RO- (Fig 3C) , which is similar to the results of reports within control groups. This population is also CD28-. Similar analyses of CD8' expansions from both I control and 3 patients on six occasions showed reduced expression of CD45RO and CD28. Nevertheless, there was heterogeneity within the CD8' expansions, with I patient 
DISCUSSION
During T-cell ontogeny, the genes for the T-cell receptor a and p chains are assembled from the variable, joining, diversity, and constant gene segments and the expression of individual gene segments has been studied in the PB of normal individuals. This profile is often termed the TCR repertoire. The report of distortions in the TCR V-segment repertoire of both CD4 and CD8 T cells in patients with paraproteinemia represented one of the first examples of disordered TCR repertoire in disease,' but it was not clear if the increased subsets represented polyclonal expansions of T cells bearing a particular TCR V segment, as is observed after superantigen activation, or whether the expansions were oligoclonal or monoclonal. Also, patients with paraproteinemia are generally over 60 years of age, and it is now clear that clonal expansions of T cells occur in the CD8 subset in healthy elderly individuals,'."' a finding that parallels the results in old mice."
The results confirm that monoclonal expansions of CD8 T cells occur in apparently healthy individuals but show that the expansions are more marked and more common in patients with a paraproteinemia. In patient H.R., a monoclonal TCRBV23 expansion represented over 79% of CD8 T cells. Two patients had two simultaneous TCRBV expansions within the CD8 subset. The clonality of the T-cell expansions was determined by sequencing of the TCR junctional region, which is specific for each individual T-cell clone. Monoclonal or biclonal expansions were observed in all cases, indicating expansion of individual T-cell clones rather than a general stimulation of all T cells bearing a particular V segment. The presence of a clonal T-cell population has been reported in 1 of 8 MM patients using a Southern blot technique to detect monoclonal rearrangement of the TCR. 13 Our data show that the true incidence of monoclonal T cells is much higher. The TCRBV-specific MoAbs used in the study only cover approximately 60% of the total CD8 T-cell population and, therefore, are likely to miss a large number of T-cell expansions. Also, not all TCRJ3V-specific antibodies were available for staining on every patient.
The TCRs found on different T cells that are specific for the same antigen often share gene segment usage and show homology in the junctional region." When the TCR junctional regions of the expansions in the patients are aligned, there is no clear homology between sequences. This is not suprising, given that they are from both CD4 and CD8 T cells and their antigen is unknown. If the expansions are idiotype-specific, they will recognize different peptide sequences, presumably in the context of different major histocompatibility complex molecules. Nevertheless, the TCRBV6.7a junctional sequences from the CD8 expansion of donor M.B. suggest shared antigenic specificity. The whole of the TCRBV6.7a expansion is derived from two different TCR sequences and, therefore, two separate T-cell clones. Although the nucleotide sequences of the two clones differ by three bases, the translated amino acid sequence is identical. The junctional region of the TCR includes nucleotides added at random and is highly variable; thus, the chances of this happening at random are extremely small. This implies strongly that the conservation is the result of selection for TCRs recognizing the same antigen. Whether or not this antigen may be derived from the paraprotein is unknown, but an example of conserved murine TCR sequences recognizing an Ig fragment has been reported. '' To gain some idea as to their possible function, we characterized the membrane phenotype of the T-cell expansions. The expansions observed in normal individuals have been mainly within the CD28-CDI lb" or CD45RO subset."' Although most expansions showed some heterogeneity, the majority expressed CD45RA rather than CD45R0, implying that they may be derived from naive populations of T cells. CDI l b was also regularly expressed, and CD8'CDI Ib' T cells are known to be increased in paraproteinemia" and appear to correlate with disease progression, being higher in MM than in monoclonal gammopathy of undetermined significance. CD57' expression was increased on both CD4 and CD8 T cells in patients, although the function of CD57' T cells remains obscure.
Three of the patients with myeloma had expansions within the CD4 subset. Sequence analysis showed that 2 were oligoclonal, with 91% of sequences derived from a single clone in 1 case. Excluding malignant disease, clonal expansions of CD4 T cells have only been reported in some large granular lymphocyte proliferations and in a recent report of patients with early rheumatoid arthriti~.'~ Clonal expansions of CD4 + T cells were not observed in the elderly control population in this report or in the control groups in other studies,'.17 suggesting that the expansions may be directly related to the paraproteinemia. It was initially felt that there were no clear abnormalities in CD4 T-cell function in MM," although an increase in the CD45RO subset occurs'' and is related to the stage of disease.'" One report described CD4 cells able to bind purified autologous F(ab')* fragments, although this was ociated with any apparent clonal T-cell expansion."
More recently idiotype-reactive T cells were shown in stage-I myeloma and were found to behave with properties suggestive of CD4Thl cells." The membrane phenotype of the CD4 expansion within patient H.R. is revealing because it is largely CD28-. This unusual subset represents less than 1 .O% of CD4+ T cells in normal individuals and has been shown to have a granular phenotype and restricted TCR expression.23 Interestingly, CD4' large granular lymphocyte expansions have been described in association with B-cell proliferation^.^^ The function of this subset is unknown, although the cells can proliferate in alloreactive stimulations and can bind to the K562 cell line, suggesting some relationship with natural killer cells.*'
A recent report has suggested a mechanism that may explain the coexistence of expansions within the CD4 and CD8 subsets observed in our patientsz6 CD8' T cells can recognize and kill autologous CD4' T cells by recognition of the TCR &chain; therefore, it is possible that the oligoclonal CD8 cells observed in patients are involved in suppressing the growth of the expanded, possibly idiotype-redctive, CD4 T cells. If the T-cell expansions are indeed related to the paraproteinemia, it i s possible that some of the expanFor personal use only. on October 23, 2017. by guest www.bloodjournal.org From sions observed in apparently healthy individuals are also related to occult paraproteinemia. The incidence of paraproteinemia in any population is related to the sensitivity of the method used for detection. Recent reports have suggested that up to 8% of people over 55 years old have a paraprotein detectable by immunofixation." Our healthy control population was screened for a paraprotein, and 1 individual had a monoclonal IgG band without background immunosuppression. No T-cell expansion was detected in this subject, but it is noteworthy that this was the only control individual that had a CD4:CD8 ratio less than 1:1, emphasizing that an inversion in this ratio is often observed in benign paraproteinemia. Nevertheless, it is likely that T-cell expansions may also arise from prolonged exposure to antigens, particularly viruses.
It is not clear if the clonal CD8 T cells are classical cytotoxic cells or if they may act in an immunoregulatory or myelosuppressive role. Mononuclear cells from MM can suppress pokeweed mitogen-induced Ig synthesis," and cells of similar phenotype can suppress bone marrow hematopoieis.*^ We have shown that clonal expansions of CD4 and CD8 T cells are observed in the PB of patients with paraproteinemia. These expansions are relatively stable over time and, from the evidence of one case, may show selection for a particular antigen. At present, the function of these populations is unclear but is the subject of investigation by several groups. 30 Once their role has been determined, it may be possible to specifically expand or deplete such T-cell populations in vivo to see whether this can influence the clinical course of the paraproteinemias.
